|
online/pay by credit card or check
or Print Registration Flyer, fax or
mail: click here
For more information on Registration:
click here
SAN FRANCISCO NEUROLOGICAL SOCIETY
FALL
DINNER MEETING
 Thursday, September 20, 2007
6:00 – 6:30 PM – Reception
6:30 – 7:30 PM – Dinner /7:30 – 9:00 PM Presentation
Marines’
Memorial Club & Hotel
609 Sutter Street, San Francisco, CA
Located at the corner of Sutter Street and Mason Street
Within walking distance from the Powell Street BART station
Tel:
415-673-6672 Several commercial parking
garages are available nearby
Mitchel S. Berger, MD
"Maximizing Extent of Tumor Resection While Minimizing Morbidity: That’s
Done, But Have We Impacted Outcome?”
Dr. Mitchel Berger
is currently the Department Chairman of Neurological Surgery at UCSF. Dr.
Berger's main clinical interests are the treatment of brain and spinal
cord tumors in adults and children and of epilepsy related to brain
tumors. He has extensive expertise in intraoperative mapping of the brain
to identify the sites of motor, sensory, and language function and thereby
avoid their involvement or injury during surgery. Dr. Berger is Director
of the Adult Hydrocephalus and Shunt Program, and he also practices in the
Neuro-Oncology Program and the Radiosurgery Program.
His current research
interests involve identifying molecular markers in gliomas as correlates
of tumor progression and prognosis. This is done in conjunction with the
Molecular Marker Core of the BTRC. He also works in conjunction with Dr.
Krys Bankiewicz to test small molecule inhibitors in brain tumors using
the drug delivery technique of convection enhanced delivery. He is a
co-investigator with Dr. John Park in UCSF's Comprehensive Cancer Center
to develop immunoliposome-directed targeted therapy for treating gliomas
that express EGF receptors. Other collaborations include functional
mapping localization of language pathways in the brain in conjunction with
Dr. Robert Knight and the Cognitive Neuroscience Graduate Program at UC
Berkeley. Dr. Berger is currently the Principal Investigator of UCSF's
SPORE Brain Tumor Program and the BTRC's Program Project Grant in Neuro-Oncology,
both of which are funded by the National Cancer Institute and NINDS.
Dr. Berger attended
medical school at the University of Miami, School of Medicine and
completed his internship and residency in neurological surgery at UCSF.
The San Francisco Neurological Society is very fortunate to have Dr.
Mitchel Berger as our guest of honor at the fall dinner meeting. Welcome!
Who Should Attend?
Neurologists,
neurosurgeons, neuroradiologists, residents and other physicians
interested in research and clinical advances in the neurosciences.
This is an activity offered by a CMA-accredited provider. Physicians
attending this course may report up to 1 hour of Category 1 credit
toward the California Medical Association Certificate in Continuing
Medical Education and the American Medical Association’s Physician’s
Recognition Award.
EDUCATIONAL OBJECTIVES:
Upon completion of
this lecture participants should be able to:
1.
Increase
the understanding of new diagnostic tests for predicting disease
progression for brain tumors.
2.
Present
new advances in the surgical management of patients with brain tumors.
3.
Critically assess the outcome of patients who have surgery for brain
tumors.
Parking
Marines' Memorial Club Guests
may park at the Olympic Garage located on 665 Sutter Street, just fifty
yards away from the club; current rate is $22.50 per day (plus tax) with
in/out privileges.
Several commercial garages are also available within a few blocks of
Marines' Memorial Club which operate 24 hours a day. Visit this website
for garages near the Marines' Memorial Club & Hotel, and around the city:
www.parkingquest.com
Acknowledgements:
The
San Francisco Neurological Society gratefully acknowledges support for its
2007 educational activities from the following generous contributors that
have provided unrestricted educational grants:
PLATINUM
SUPPORTERS:
Allergan, Inc.
Novartis Pharmaceuticals
Teva Neurosciences, Inc.
Supporters:
Boehringer Ingelheim
Pharmaceuticals, Inc.
Forest
Pharmaceuticals, Inc.
GlaxoSmithKline
Medtronic Neurological
Pfizer
For more information please contact Karen Bertani at kbertani@sfneurological.org.
For more information:
Karen A. Bertani,
CMP
Executive Director
San Francisco Neurological Society
2226A Westborough Blvd. #409
South San Francisco, CA 94080
NEW
Tel: Phone: 415-206-9603; NEW Fax: 415-206-0385
E-mail:
kbertani@sfneurological.org
The San Francisco Neurological
Society is an organization of physicians with a dedicated interest in
the clinical neurosciences. The Society is committed to the continuing
medical education of its members and has an obligation to its members and
to the public to provide ongoing educational programs designed to improve
patient care and foster scholarly activity in the neurosciences. This
obligation includes not only imparting to the membership an increased
understanding of neurological diseases through lectures on clinical and
basic research, but also making them aware of community and public health
issues related to neurological illnesses and preventive medicine. The
Society is a CMA-accredited provider. Physicians attending this course may
report up to 8 hours of Category 1 credit toward the California Medical
Association Certificate in Continuing Medical Education and the American
Medical Association’s Physician’s Recognition Award.
|
